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OUR GOAL must be to devise short-term
tests for carcinogens at two levels ofsophisti-
cation. Simple preliminary (Phase 1) screen-
ing tests are needed to detect carcinogens; in
these, qualitative information would be
acceptable. The emphasis in their design
should be to provide sensitive tests which
minimize species and tissue differences in
response. InPhase1tests, falsepositives would
be more acceptable than false negatives.
Chemicals giving positive results in Phase 1
would then be examined in more elaborate
(Phase 2) tests aimed at providing quantita-
tive information and characterizing species
and tissue differences in response.
To achieve broad applicability, both
Phases 1 and 2 screening tests for carcinogens
must incorporate two key components: a
metabolism system able to generate any
active metabolites which may be formed in
man; and a response system which reflects
the essential processes in chemical careino-
genesis. It is possible to combine the meta-
bolism and response systems in a single pre-
paration (e.g., freshly isolated hepatocytes)
but the range ofpotential endpoints isthereby
restricted to those not involving cell division
(Bridges & Fry, 1978a). Although much
effort is being expended on Phase 1 tests at
present, comparatively little attention is
being given to Phase 2 tests. Interestingly,
the development of short-term tests for
identifying promoters (which might justi-
fiably be considered as necessary as effective
tests for initiators) is also largely ignored.
Sample preparation
A knowledge of the chemical and physical
properties of the sample, particularly its
stability, is valuable. It is essential that the
sample must be in a form in which each
component is able to gainready access to both
the metabolism and the response systems.
This usually entails dissolving the sample in
an organic solvent such as DMSO, ethanol or
acetone. It is important to keep the final
volume of solvent added to the test low
(usually >041%) to avoid damage to the
metabolism and response systems. Sonication
of the sample with the medium just before
adding the metabolism and response systems
can be used as an alternative. Checks should
be made that none of the components of the
sample precipitate out of solution or bind to
the surfaces ofthe test apparatus. Approaches
for administering volatile and multiple-
component samples are still inadequate. Care
must be taken in devising equipment for
handling volatile materials to ensure that the
oxygen tension is sufficiently high to allow
the oxidative metabolism ofthe metabolizing
system to function adequately.
Selection of the metabolism system
Since the liver is the predominant drug-
metabolizing organ in all mammals, the
metabolism system is normally derived from
liver. Species- and tissue-specific effects tend
to be lost when the liver is homogenized and
fractionated. By using cellular fractions
supplemented with NADPH2 the relative
proportion of active metabolites is generally
much greater than in intact cells, because the
major conjugation enzymes (which have a
predominantly detoxication role) are unable
to function when they are not provided with
their requisite cofactors.
Care must be taken in both preparing and
storing cell fractions to ensure that there is
no selective damage to the drug-metabolizing
enzymes. (Microsomal amine oxidase and
phenobarbitone-type cytochrome P450 are
especially vulnerable to damage.) Livers from
animals pretreated with various agents can
be used to increase the activity ofthe mixed-
function oxidases and hence enhance the
formation of active metabolites. However it
must be borne in mind that all inducers cause
a differential induction of the mixed-function
oxidases, which may result in a very distorted
profile of metabolites compared with the
control situation. Furthermore, residues of
the inducer may persist in the liver prepara-
tion, and this could cause selective inhibition
of some of the enzymes of the metabolism
system or modification in the response
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system. It is possible to manipulate the
metabolism system in a number of other
ways:
-changing cofactor levels of NADPH2 or
adding additional cofactors such NADH2,
UDPGA or PAPS, thereby allowing other
enzymes in the preparation to be ex-
pressed;
-altering the state of oxygenation. pH etc.
of the test conditions;
-adding selective inhibitors (e.g. competitive
substrates) or non-competitive inhibitors
(e.g. piperonyl butoxide);
-using selective activators (e.g. betametha-
sone, acetone, : napthoflavone); and
-modifying the nutrient content of the diet
of the animals before making the liver
preparation.
These latter approaches are useful as tools
to understanding the contributions of certain
types of reactive metabolites, and could play
an important role in Phase 2 tests, but they
are unlikely to be ofvalue in Phase 1 tests.
Although enhanced sensitivity is usually
achieved by using cell fractions, there is a
danger that the role of metabolites which
have little ifanyrelevance to cancer initiation
in vivo may be emphasized. Such a situation
might arise because the metabolite would
normally be detoxicated before it could react
with essential target macromolecules, or
because it would only be formed at cytotoxic
dose levels of chemical.
Intact cells may also be used as the active
metabolite-generating source. However, it is
apparent that isolated hepatocytes tend to
show a differential loss of mixed-function
oxidases within 24 h of their isolation
(Bridges & Fry, 1978b). Cell lines derived
from hepatocytes are almost entirely deficient
in the major xenobiotic metabolizing form of
mixed-function oxidase (phenobarbitone
P450) in adult liver, and hence such lines
produce an abnormal metabolism of most
compounds. A similar problem applies to the
use offreshly isolated foetal hepatocytes. The
cell lines at present available are quite
unsuitable as a feeder layer in short-term
tests, except where restricted groups of
chemicals are being examined. Freshly
derived intact cell preparations from human
tissues offer considerable potential as the
metabolism system for Phase 2 tests.
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Interfacing the metabolism and response
system
Metabolites formed by the metabolism
system must be able to gain ready access to
the response system. The physical separation
between the two systems should therefore be
minimal, and the medium between the two
systems should, ideally, allow free diffusion
ofboth polar and non-polar metabolites. This
is seldom accomplished in the present tests.
Except in the case of aromatic amines, the
major reactive metabolites tend to be lipo-
philic, so that for general application a lipid
environment between the metabolism and
response systems is more desirable than a
polar one. Care must be taken to ensure that
changes such as lipid peroxidation or hydroly-
sis of proteins in the metabolism system as a
result ofthe action ofa chemical, do not cause
modifications to the response system. This is
particularly important in response systems
which are critically dependent on the level
ofnutrient in their environment, e.g. bacteria
showing dependence for growth on the
availability ofcertain amino acids.
Selection of response systems
Many biological changes have been asso-
ciated with chemical carcinogens: binding of
metabolites to DNA, damage to DNA and
chromosomes, DNA repair, qualitative and
quantitative changes in cell growth, produc-
tion of abnormal ("marker") proteins,
changes in antigenicity of the plasma
membrane, differential changes in cellular
enzymes and loss of ribosomes from the
endoplasmic reticulum. In the light of our
reasonably good understanding of how DNA
might be involved in cancer initiation by
chemicals and the paucity of our knowledge
of other mechanisms of cancer initiation and
post initiation events, most of the present
tests are aimed, perhaps understandably, at
determining endpoints associated with DNA
and chromosomal changes. In view of our
uncertainty about the key events in chemical
carcinogenesis it is essential that in the
response system particularly, Phase 1 tests
should cover a variety of different biological
preparations, and that some should allow for
initiation events other than direct interaction
of the chemical and/or its metabolites with
DNA. It is important that in the development
of each test the problem of false negatives
501502 BRITISH ASSOCIATION FOR CANCER RESEARCH
and false positives is thoroughly researched
in order to understand the causes of the
limitations. It is essential that each test is
validated using a range ofchemical structures
which in vivo have different tissue and
species specificities. It is necessary to estab-
lish for each chemical a reproducible dose-
response relationship and to be able to
distinguish between subtle changes likely to
be associated in vivo with tumour develop-
ment and gross effects likely to result in cell
death. Much more effort must be expended
on developing reliable quality control; a
single chemical standard is most unlikely to
be adequate to control the quality of
combined metabolism and response systems.
The future
It is to be hoped that the progressive
development of improved short-term ap-
proaches for detecting and characterizing
carcinogens and related compounds will not
be inhibited by the natural desire to obtain
rapidly a universal short-term test for
screening carcinogens.
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BACTERIAL MUTATION TESTS fall into a
general category of short-term assays for
carcinogen screening which are based on the
unifying hypothesis that carcinogens charac-
teristically react with, modify, induce the
repair of, interrupt the replication of, or
otherwise alter the structure, function or
subsequent fate of DNA; in other words,
most carcinogens have been found to cause
DNA damage. The detection ofDNA damage
has therefore become a major preoccupation
of those interested in determining which, of
those many thousands of chemicals already
in use, or in development, are most likely to
have carcinogenic properties. At present, the
most sensitive, reliable, rapid and universally
applicable methods for detecting DNA
damage are thosebasedonbacterial mutation.
Mutation may be defined as a stable herit-
able change in a DNA nucleotide sequence
which is detected as a phenotypic change.
Such heritable changes may be due to base
substitutions (transitions, transversions)
frame shifts (deletion or addition of one or
few nucleotide pairs) large deletions, inser-
tions or translocations. Few if any mutagens
induce only one type of mutational change,
but instead exhibit a characteristic muta-
tional spectrum which depends on the nature
of the primary DNA alteration (modification
of a base, phosphate or sugar, strand break,
or incorporation of a modified base) and the
secondary effects of the organisms' response
to the DNA alteration, by the operation of
various DNA-repair systems and by replica-
tion of daughter strands upon a modified
template. The same mutagen may therefore
induce different mutational patterns in
organisms of different genetic background.
Mutations may be detected by methods
which assay for forward or reverse mutation.
Forward mutation (e.g. from drug sensitivity
to drug resistance) have the theoretical
advantage ofpresenting a large genetic target
and should therefore detect many of the
DNA alterations mentioned above, including
deletions, all of which may be expressed by
the same phenotype. Reverse mutation
assays (e.g. amino acid auxotrophy to proto-
trophy) use bacteria already mutant at an
easily detected locus, and the test consists of
determining the rate at which the test
chemical induces a second mutation which
abolishes or suppresses the effect of the pre-
existing mutation. The genetic target is
therefore small, selective and specific. Several